Panax Ginseng Enhances Cognitive Performance in Alzheimer Disease
暂无分享,去创建一个
Soon-Tae Lee | K. Chu | Soon-Tae Lee | J. Heo | Manho Kim | Kon Chu | Manho Kim | Jae-Hyeok Heo | Ji-Young Sim | Ji-Young Sim
[1] Katsuko Komatsu,et al. Search for Natural Products Related to Regeneration of the Neuronal Network , 2005, Neurosignals.
[2] D. Kennedy,et al. Dose Dependent Changes in Cognitive Performance and Mood following Acute Administration of Ginseng to Healthy Young Volunteers , 2001, Nutritional neuroscience.
[3] D. Kennedy,et al. Ginseng: potential for the enhancement of cognitive performance and mood , 2003, Pharmacology Biochemistry and Behavior.
[4] K. Nam. The Comparative Understanding between Red Ginseng and White Ginsengs, Processed Ginsengs (Panax ginseng C. A. Meyer) , 2005 .
[5] Sum-Yan Ng,et al. Effects of ginseng saponins on β-amyloid-induced amnesia in rats , 2006 .
[6] G. Wilcock,et al. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial , 2000, BMJ : British Medical Journal.
[7] Yong Cheng,et al. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action , 2005, Acta Pharmacologica Sinica.
[8] M. Meselhy,et al. Aβ(25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponins , 2004, Neuropsychopharmacology.
[9] S. Joo,et al. Potential effects of microglial activation induced by ginsenoside Rg3 in rat primary culture: Enhancement of type a macrophage scavenger receptor expression , 2005, Archives of pharmacal research.
[10] J. L. Stringer,et al. Protective effects of ginseng components in a rodent model of neurodegeneration , 2005, Annals of neurology.
[11] B. McEwen,et al. Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. , 1997, Brain research. Molecular brain research.
[12] W. F. Mcdaniel,et al. Ginseng improves strategic learning by normal and brain‐damaged rats , 1998, Neuroreport.
[13] K. Chiba,et al. Effect of polyacetylenes on the neurite outgrowth of neuronal culture cells and scopolamine-induced memory impairment in mice. , 2001, Biological & pharmaceutical bulletin.
[14] Cuk-Seong Kim,et al. Effect of Korea red ginseng on cerebral blood flow and superoxide production. , 2002, Acta pharmacologica Sinica.
[15] N. Nishiyama,et al. Differential effects of ginsenoside Rb1 and malonylginsenoside Rb1 on long-term potentiation in the dentate gyrus of rats , 1994, Brain Research.
[16] M. Marcoli,et al. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. , 1986, Journal of ethnopharmacology.
[17] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[18] J. Fitzloff,et al. HPLC DETERMINATION OF GINSENOSIDES CONTENT IN GINSENG DIETARY SUPPLEMENTS USING ULTRAVIOLET DETECTION , 2002 .
[19] M. Sakanaka,et al. Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root , 1997, Neuroscience Research.
[20] C. Yuan,et al. Ginseng pharmacology: multiple constituents and multiple actions. , 1999, Biochemical pharmacology.
[21] David D. Kitts,et al. Antioxidant properties of a North American ginseng extract , 2004, Molecular and Cellular Biochemistry.
[22] E. Perry,et al. Non‐ginsenoside nicotinic activity in ginseng species , 1999, Phytotherapy research : PTR.
[23] Kinzo Matsumoto,et al. Panax ginseng extract improves the scopolamine-induced disruption of 8-arm radial maze performance in rats. , 1995, Biological & pharmaceutical bulletin.
[24] 남기열. The Comparative Understanding between Red Ginseng and White Ginsengs,Processed Ginsengs (Panax ginseng C. A. Meyer) , 2005 .
[25] J. H. Boo,et al. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice , 2001, Journal of neuroscience research.
[26] T. Ono,et al. Effects of nonsaponin fraction of red ginseng on learning deficits in aged rats , 2004, Physiology & Behavior.
[27] K. Davis,et al. A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.
[28] G. Wilcock,et al. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group. , 2000, BMJ.
[29] K. Kudo,et al. Effects of ginseng saponins on responses induced by various receptor stimuli. , 1999, European journal of pharmacology.
[30] J. Sonne,et al. A DOUBLE-MASKED STUDY OF THE EFFECTS OF GINSENG ON COGNITIVE FUNCTIONS , 1996 .
[31] C. Eckman,et al. Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] Li-hong Shen,et al. Ginsenoside Rg1 promotes proliferation of hippocampal progenitor cells , 2004, Neurological research.